Thousands with chronic liver cirrhosis can be saved or lead improved lives now
Zurich, Switzerland, 4. December 2019 Chronic liver cirrhosis, mainly caused by Hepatitis B and C, has for long been a huge problem without any option for treatment. However, Baermed Liver Cell Technologies has developed the HMI treatment, which are "mini-livers" retrieved from a patient’s own body. The addressable market for the HMI treatment is calculated at over $25 billion in Asia and Europe alone. This treatment has been fully developed and is currently the only option (
